王恒樑 Hengliang Wang

从事基因工程疫苗和微生物功能基因组学研究，主持多个临床试验研究，近5年在Nature，Nature Communications等期刊发表多篇作为通讯的相关文章。

Engaged in research on genetic engineering vaccines and microbial functional genomics, leading multiple clinical trial studies. In the past 5 years, has published multiple articles as corresponding author in journals such as Nature and Nature Communications.